Search details
1.
Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's Disease and Multiple Sclerosis.
J Neurosci
; 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38830764
2.
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aß42:Aß40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
J Neurosci
; 40(9): 1956-1974, 2020 02 26.
Article
in English
| MEDLINE | ID: mdl-31980586
3.
TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse models.
iScience
; 26(11): 108362, 2023 Nov 17.
Article
in English
| MEDLINE | ID: mdl-37965143
4.
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by ß-amyloid pathology.
Neuron
; 109(8): 1283-1301.e6, 2021 04 21.
Article
in English
| MEDLINE | ID: mdl-33675684
5.
Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aß.
Alzheimers Res Ther
; 11(1): 97, 2019 12 01.
Article
in English
| MEDLINE | ID: mdl-31787113
6.
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.
Neoplasia
; 9(7): 601-13, 2007 Jul.
Article
in English
| MEDLINE | ID: mdl-17710163
7.
A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Cancer Immunol Immunother
; 52(6): 367-77, 2003 Jun.
Article
in English
| MEDLINE | ID: mdl-12669243
Results
1 -
7
de 7
1
Next >
>>